Oregon and Lantern collaborate to develop drug candidate for various cancer indications
Pharma Times
by Jen Brogan
21h ago
Anticancer drugs will be responsible for 90% of nearly 612,000 predicted US cancer deaths in 2024 ..read more
Visit website
OneChain’s CAR T trial treats its first cortical T-cell ALL patient
Pharma Times
by Jen Brogan
21h ago
The subtype accounts for 20% of all T-cell leukaemias, a rare form of blood cancer which produces too many abnormal T-cells ..read more
Visit website
Johns Hopkins scientists depict molecular pathway to track replication in cancer cells
Pharma Times
by Jen Brogan
2d ago
The findings could potentially lead to new therapies and could stop the growth of cancers ..read more
Visit website
Chiesi and Gossamer collaborate to develop drug to treat respiratory diseases
Pharma Times
by Jen Brogan
2d ago
Gossamer’s seralutinib is designed to treat pulmonary arterial hypertension and other indications ..read more
Visit website
NHS to roll out fibre optic laser therapy to prevent seizures in epileptic patients
Pharma Times
by Jen Brogan
3d ago
The chronic brain disease that causes seizures currently affects around 600,000 people living in the UK  ..read more
Visit website
Francis Crick Institute and Broken String Biosciences partner for ALS research
Pharma Times
by Jen Brogan
3d ago
The rare and fatal progressive neurodegenerative disease is estimated to affect 5,000 people in the UK ..read more
Visit website
Silent plight
Pharma Times
by John Pinching
1w ago
Why a new approach is needed for primary biliary cholangitis trials ..read more
Visit website
Cambridge researchers develop robotic nerve devices for neurological conditions
Pharma Times
by Jen Brogan
1w ago
Neurological disorders, such as epilepsy or chronic pain, affect over three billion people worldwide ..read more
Visit website
International phase 3 clinical trial for new melanoma treatment recruits first patients
Pharma Times
by Jen Brogan
1w ago
The INTerpath-001 trial is evaluating Moderna/Merck’s mRNA-4157 in combination with Merck’s Keytruda ..read more
Visit website
Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
Pharma Times
by Jen Brogan
1w ago
The inherited disorder is caused by genetic mutations that affects haemoglobin production ..read more
Visit website

Follow Pharma Times on FeedSpot

Continue with Google
Continue with Apple
OR